Obsidian Therapeutics, Inc. Common Stock

Obsidian Therapeutics, Inc. Common Stock (OBX) Price Prediction & Forecast

$14.590

+0.349 (+2.39%)At close

Price Predictions

1-Day Price Prediction
-1.06%
1-Week Prediction
-6.69%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

OBX Prediction & Forecast by Similar Chart Analysis

Alphio's OBX stock price prediction model matches the current Obsidian Therapeutics, Inc. Common Stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.38 (-1.06%). The 1-week path is $13.56 (-6.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Obsidian Therapeutics, Inc. Common Stock Stock?

Galera Therapeutics Inc (OBX) is a good buy right now due to its recent price increase of 18.78% over the last five days and a strong analyst price target average of $39.67, suggesting a potential upside of approximately 184% from the current price of $13.98. The RSI is at 68.36, indicating strong momentum, although it is approaching overbought territory. The main risk is the company's negative net income of -$4,707,000 in Q4 2024, which highlights ongoing financial challenges.

OBX stock price ended at $14.59 on Wednesday, after rising +2.39%

Obsidian Therapeutics, Inc. Common Stock (OBX) last closed at $14.5299997, losing -0.41%. These facts feed the 1-day and 1-week OBX price prediction above.

Forecast Drivers

Obsidian Therapeutics, Inc. Common Stock (OBX) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

Similar Chart Patterns

Stocks whose recent price path most closely matches OBX, ranked by similarity.

Seasonality analysis for OBX

Loading chart…

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading